相似文献
1
Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling.
Clin Pharmacokinet. 2020 Nov;59(11):1433-1450. doi: 10.1007/s40262-020-00897-9.
2
Raltegravir-based Postnatal HIV Prophylaxis Therapy in a Neonate After in Utero Dolutegravir Exposure.
Pediatr Infect Dis J. 2022 Feb 1;41(2):131-132. doi: 10.1097/INF.0000000000003364.
3
Pharmacokinetic profiles of boosted darunavir, dolutegravir and lamivudine in aging people living with HIV.
AIDS. 2020 Jan 1;34(1):103-108. doi: 10.1097/QAD.0000000000002372.
4
Assessment of Maternal and Fetal Dolutegravir Exposure by Integrating Ex Vivo Placental Perfusion Data and Physiologically-Based Pharmacokinetic Modeling.
Clin Pharmacol Ther. 2020 Jun;107(6):1352-1361. doi: 10.1002/cpt.1748. Epub 2020 Jan 24.
5
Pharmacokinetics of HIV-Integrase Inhibitors During Pregnancy: Mechanisms, Clinical Implications and Knowledge Gaps.
Clin Pharmacokinet. 2019 Mar;58(3):309-323. doi: 10.1007/s40262-018-0684-z.
6
Assessment of drug interaction potential between the HCV direct-acting antiviral agents elbasvir/grazoprevir and the HIV integrase inhibitors raltegravir and dolutegravir.
J Antimicrob Chemother. 2019 Mar 1;74(3):710-717. doi: 10.1093/jac/dky465.
7
Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors.
Clin Pharmacokinet. 2017 Jan;56(1):25-40. doi: 10.1007/s40262-016-0424-1.
8
Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors: An Updated Review.
Clin Pharmacokinet. 2020 Sep;59(9):1085-1107. doi: 10.1007/s40262-020-00898-8.
9
The promise of paediatric dolutegravir.
J Int AIDS Soc. 2021 Jan;24(1):e25660. doi: 10.1002/jia2.25660.
10
Is There a Safety Signal for Dolutegravir and Integrase Inhibitors During Pregnancy?
J Acquir Immune Defic Syndr. 2019 Aug 1;81(4):481-486. doi: 10.1097/QAI.0000000000002065.
引用本文的文献
1
Safety and Efficacy of Antiviral Drugs and Vaccines in Pregnant Women: Insights from Physiologically Based Pharmacokinetic Modeling and Integration of Viral Infection Dynamics.
Vaccines (Basel). 2024 Jul 16;12(7):782. doi: 10.3390/vaccines12070782.
2
Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential.
Expert Rev Anti Infect Ther. 2024 Apr;22(4):153-167. doi: 10.1080/14787210.2024.2334054. Epub 2024 Mar 27.
3
Physiologically-based pharmacokinetic modelling of long-acting injectable cabotegravir and rilpivirine in pregnancy.
Br J Clin Pharmacol. 2025 Apr;91(4):989-1002. doi: 10.1111/bcp.16006. Epub 2024 Feb 10.
4
Application of Physiologically Based Pharmacokinetic Modeling to Predict Maternal Pharmacokinetics and Fetal Exposure to Oxcarbazepine.
Pharmaceutics. 2022 Nov 3;14(11):2367. doi: 10.3390/pharmaceutics14112367.
5
Maternal-Fetal Pharmacology of Drugs: A Review of Current Status of the Application of Physiologically Based Pharmacokinetic Models.
Front Pediatr. 2021 Nov 3;9:733823. doi: 10.3389/fped.2021.733823. eCollection 2021.
6
Mechanistic Modeling of Placental Drug Transfer in Humans: How Do Differences in Maternal/Fetal Fraction of Unbound Drug and Placental Influx/Efflux Transfer Rates Affect Fetal Pharmacokinetics?
Front Pediatr. 2021 Oct 18;9:723006. doi: 10.3389/fped.2021.723006. eCollection 2021.
7
Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development.
Front Pediatr. 2021 Oct 13;9:721059. doi: 10.3389/fped.2021.721059. eCollection 2021.
8
Mechanistic Coupling of a Novel Cotyledon Perfusion Model and a Physiologically Based Pharmacokinetic Model to Predict Fetal Acetaminophen Pharmacokinetics at Delivery.
Front Pediatr. 2021 Sep 23;9:733520. doi: 10.3389/fped.2021.733520. eCollection 2021.
9
Mechanistic Modeling of Maternal Lymphoid and Fetal Plasma Antiretroviral Exposure During the Third Trimester.
Front Pediatr. 2021 Sep 20;9:734122. doi: 10.3389/fped.2021.734122. eCollection 2021.
10
Regulatory Considerations for the Mother, Fetus and Neonate in Fetal Pharmacology Modeling.
Front Pediatr. 2021 Jul 26;9:698611. doi: 10.3389/fped.2021.698611. eCollection 2021.
本文引用的文献
1
Impact of gastrointestinal physiology on drug absorption in special populations--An UNGAP review.
Eur J Pharm Sci. 2020 Apr 30;147:105280. doi: 10.1016/j.ejps.2020.105280. Epub 2020 Feb 25.
2
The Effect of Pregnancy on the Pharmacokinetics of Total and Unbound Dolutegravir and Its Main Metabolite in Women Living With Human Immunodeficiency Virus.
Clin Infect Dis. 2021 Jan 23;72(1):121-127. doi: 10.1093/cid/ciaa006.
3
Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study).
PLoS Med. 2019 Sep 20;16(9):e1002895. doi: 10.1371/journal.pmed.1002895. eCollection 2019 Sep.
4
Drug Transporters Expressed in the Human Placenta and Models for Studying Maternal-Fetal Drug Transfer.
J Clin Pharmacol. 2019 Sep;59 Suppl 1(Suppl 1):S70-S81. doi: 10.1002/jcph.1491.
5
Physiologically Based Pharmacokinetic Models to Predict Maternal Pharmacokinetics and Fetal Exposure to Emtricitabine and Acyclovir.
J Clin Pharmacol. 2020 Feb;60(2):240-255. doi: 10.1002/jcph.1515. Epub 2019 Sep 6.
6
Physiologically Based Pharmacokinetic Modeling to Characterize Acetaminophen Pharmacokinetics and N-Acetyl-p-Benzoquinone Imine (NAPQI) Formation in Non-Pregnant and Pregnant Women.
Clin Pharmacokinet. 2020 Jan;59(1):97-110. doi: 10.1007/s40262-019-00799-5.
7
Clinical Extrapolation of the Effects of Dolutegravir and Other HIV Integrase Inhibitors on Folate Transport Pathways.
Drug Metab Dispos. 2019 Aug;47(8):890-898. doi: 10.1124/dmd.119.087635. Epub 2019 Jun 5.
8
Pharmacokinetics of dolutegravir 100 mg once daily with rifampicin.
Int J Antimicrob Agents. 2019 Aug;54(2):202-206. doi: 10.1016/j.ijantimicag.2019.04.009. Epub 2019 Apr 16.
9
Reconsidering the Number of Women With HIV Infection Who Give Birth Annually in the United States.
Public Health Rep. 2018 Nov;133(6):637-643. doi: 10.1177/0033354918800466. Epub 2018 Sep 28.
10
Physiologically Based Pharmacokinetic Modeling in Pregnancy: A Systematic Review of Published Models.
Clin Pharmacol Ther. 2018 Dec;104(6):1110-1124. doi: 10.1002/cpt.1084. Epub 2018 May 6.
Zotero 插件